New User:
-or-
Username:
Password:
Forgot your password?
News Breaks
November 9, 2009
07:33 EDTARIA
theflyonthewall.com: Ariad Pharmaceuticals upgraded to Overweight at JP Morgan
As reported earlier, JP Morgan upgraded Ariad Pharmaceuticals to Overweight from Neutral. The firm believes Phase I and Phase III data announcements over the next 3-6 months will serve as positive catalysts and set a $6 price target on the stock. :theflyonthewall.com



News For ARIA From The Last 14 Days
Check below for free stories on ARIA the last two weeks.
There is 1 item on the Fly with pertinent information.
Sign up for a free trial to see the rest of the stories you've been missing.
February 13, 2012
16:15 EDTARIA
theflyonthewall.com: Ariad initiated with an Outperform at RBC Capital
Target $20. :theflyonthewall.com